Drug pricing controls detrimental: Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw, CMD of Biocon, tells NDTV that the NPPA’s decision to add more drugs under price control will have a detrimental impact on the industry and the pharmaceutical sector has been completely overlooked in this Budget.
Watch more videos: http://www.ndtv.com/video
Don't miss the stories followIndiaVision Social and Lifestyle and let's be smart!
